Back to Journals » Journal of Pain Research » Volume 18
Suicidal Ideation and Self-Injury in Trigeminal Neuralgia
Authors Fishbein NS, Bakhshaie J, Greenberg J
Received 29 August 2024
Accepted for publication 4 April 2025
Published 12 April 2025 Volume 2025:18 Pages 2003—2010
DOI https://doi.org/10.2147/JPR.S493649
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Prof. Dr. Alexandre F DaSilva
Nathan S Fishbein,1 Jafar Bakhshaie,2,3 Jonathan Greenberg2,3
1Psychology Department, Fordham University, Bronx, NY, USA; 2Center for Health Outcomes and Interdisciplinary Research, Massachusetts General Hospital, Boston, MA, USA; 3Harvard Medical School, Boston, MA, USA
Correspondence: Jonathan Greenberg, Center for Health Outcomes and Interdisciplinary Research, Massachusetts General Hospital, Harvard Medical School, 1 Bowdoin Square, 6th Floor, Suite 648, Boston, MA, 02114, USA, Email [email protected]
Purpose: Trigeminal neuralgia is commonly associated with emotional distress and unique challenges that may increase the risk of suicidality. Nevertheless, suicidality remains understudied in this population. This study reports rates and severity of suicidal ideation and self-injury and the association between suicidality, emotional distress, and pain intensity in a large sample of adults with trigeminal neuralgia and related neuralgias.
Patients and Methods: We recruited 229 adults with trigeminal neuralgia and other related conditions to complete a cross-sectional survey assessing suicidal ideation, self-injury, and emotional distress. We analyzed rates and severity of suicidal ideation and self-injury. We performed independent samples t-tests to compare the severity of suicidality between respondents with high and low levels of anxiety, depression, and pain intensity.
Results: Over a third (34.6%) of respondents reported at least some thoughts of suicide in the past 2 weeks, 27.6% reported thinking the world would be better off without them, 57.7% reported thinking about their own death, 14.0% reported thinking about hurting themselves, 2.6% reported hurting themselves purposefully, and 1.3% reported cutting or burning themselves. Over a third of respondents (39.1%) had elevated anxiety, and suicidality was more severe among those with elevated anxiety than among those without (n = 214, p < 0.001). Over a quarter of respondents (28.5%) had elevated depression, and suicidality was more severe among those with elevated depression than among those without (n = 213, p < 0.001). Almost two-thirds of respondents (62.9%) had elevated pain intensity, and suicidality was more severe among those with elevated pain intensity than among those without (n = 228, p < 0.001).
Conclusion: Suicidality is an urgent yet under-addressed concern among adults with trigeminal neuralgia and is associated with high rates of anxiety, depression, and pain intensity in this population. We propose recommendations to enhance suicide screening and develop interventions to reduce suicide risk among those with chronic orofacial pain.
Keywords: suicide, emotional distress, pain, anxiety, depression
Introduction
Chronic orofacial pain (ie, pain in the face, mouth, or jaw for at least one day each month for the last 3 months) is often debilitating and challenging to treat.1 Individuals with chronic orofacial pain often experience marked emotional distress and may be at a heightened risk for suicidal ideation and behavior.2,3 Literature focusing on chronic pain suggests that those with chronic pain may be twice as likely to report suicidal behaviors or attempt suicide as those without chronic pain.3 However, to date, suicidal ideation and self-injurious behaviors specifically among those with chronic orofacial pain remains under-studied and under-addressed.
People with chronic orofacial pain experience unique challenges that may increase distress and exacerbate suicidal ideation. Chronic orofacial pain can entail difficulty talking for sustained periods of time, making socializing difficult and leading to social isolation.4 Many report intense pain that is highly unpredictable and difficult to manage.4 Individuals with chronic orofacial pain are often misdiagnosed and undergo unnecessary and sometimes painful or harmful treatments.5 Pharmacological treatment of chronic orofacial pain is often ineffective and entails a host of negative side effects that can further disrupt everyday functioning.4,6 Additionally, individuals with chronic orofacial pain have reported struggling to receive diagnoses, not being believed by their medical providers, frequently feeling stigmatized when seeking medical care, and frustration with the inadequacy of current pain management options.4,7,8 Against this backdrop of stressors, alarming levels of anxiety and depression have been reported among individuals with chronic orofacial pain,9–11 with some showing that elevated anxiety may predict the onset of chronic orofacial pain.12 These elevated levels of emotional distress may increase suicide risk for this population,13 and current literature suggests that suicidal ideation may be elevated among those with chronic orofacial pain and that suicidal behavior may be correlated with pain intensity in this population.14,15 However, this research has been limited by small sample sizes, regionally biased samples, and a focus on temporomandibular disorders, which are just one of many possible causes of orofacial pain.14,15 Further research on suicide among individuals with chronic orofacial pain is urgently needed.3,16
Among types of chronic orofacial pain, relatively little is known about the psychosocial functioning associated with trigeminal neuralgia. Those with trigeminal neuralgia often undergo unnecessary procedures prior to being correctly diagnosed, and research has shown that trigeminal neuralgia and associated pain frequently interfere with daily activities.17 One recent systematic review found mild-to-moderate levels of depression and moderate-to-severe levels of anxiety in trigeminal neuralgia patients, and further research is needed to identify if such elevations in emotional distress are associated with increased suicide risk among those with trigeminal neuralgia.18
This descriptive study aims to report rates and severity of suicidal ideation and self-injurious behaviors among individuals with trigeminal neuralgia and other related neuralgias. A secondary aim is to explore the association between suicidality, emotional distress, and pain intensity in this population.
Methods
Procedures
We recruited 229 adults with trigeminal neuralgia and related conditions (see Table 1 for diagnoses) through a bulletin distributed by the Facial Pain Association (formally known as the Trigeminal Neuralgia Association; see LaRowe et al 2024 for further details on study procedures).19 Recruitment began on 12/2023 and lasted until 01/2024. Inclusion criteria for the current study were as follows: >18 years of age, self-reported capacity to speak and write English at a sixth-grade level, living in the United States, nonmalignant orofacial pain for 3 months or more, and self-reported diagnosis of trigeminal neuralgia or related condition(s) including other trigeminal neuropathy, glossopharyngeal neuralgia, and multiple cooccurring orofacial pain diagnoses. Exclusion criteria were as follows: diagnosis of burning mouth syndrome, temporomandibular disorder, and persistent idiopathic facial pain. Participants were fully informed of the purpose of the study and provided consent. Participants then completed a survey through REDCap, a HIPAA secure online survey platform. All study procedures were approved by the Massachusetts General Hospital IRB and comply with the Declaration of Helsinki. All diagnoses were classified in accordance with the International Classification of Orofacial Pain (ICOP), first edition.
![]() |
Table 1 Demographic Characteristics |
Measures
Demographics and Clinical Characteristics
Participants reported their age, gender, ethnicity, education level, employment, and marital status. Further, they reported their facial pain diagnosis (if known), pain duration, mental health history, and currently used pain or mood medication.
Suicidality
The suicidality subscale of the Inventory of Depression and Anxiety Symptoms (IDAS) is a six-item self-report questionnaire that assesses suicidal ideation and self-injury.20 Responses are scored on five-point Likert scale, with higher total scores (range 0–30) indicating higher levels of suicidal ideation.
Anxiety
The Overall Anxiety Severity and Impairment Scale (OASIS) is a five-item self-report questionnaire that assesses the severity and impairment of anxiety disorders.21 Responses are scored on a five-point Likert scale and summed to calculate a total score, with higher total scores (range 0–20) indicating more severe and impairing anxiety. A cutoff score of eight is used to identify respondents who are likely to meet criteria for anxiety diagnoses.21
Depression
The Overall Depression Severity and Impairment Scale (ODSIS) is a five-item self-report questionnaire that assesses depression severity and impairment.22 Responses are scored on a five-point Likert scale and summed to calculate a total score, with higher total scores (range 0–20) indicating more severe and impairing depression. A cutoff score of eight is used to identify respondents who are likely to meet criteria for depression diagnoses.22
Pain Intensity
The first item of the Pain, Enjoyment of Life, and General Activity scale (PEG-3) assesses average pain intensity over the past week.23 Responses are recorded on a ten-point Likert scale, with higher scores (range 0–10) indicating more intense pain. A cut score of 5 is used to identify respondents with elevated pain intensity.23
Analytic Strategy
We first examined data for univariate normality and the presence of outliers. We next performed descriptive analyses to assess the percentage of participants endorsing various levels of suicidal ideation and self-injurious behaviors in response to each IDAS question and the mean and standard deviation of the IDAS sum scores. We then performed independent samples t-tests to compare the severity of suicidality (ie, sum IDAS scores) between participants with above cut-score and below cut-score levels of anxiety, depression, and pain anxiety. Lastly, we examined bivariate correlations between severity of suicidality and both anxiety and depression to assess overlap in these constructs.
Results
Of all respondents, 229 participants completed the IDAS, 215 participants completed the OASIS, 214 participants completed the ODSIS, and 229 participants completed the first item of the PEG-3. Demographic characteristics of the sample are listed in Table 1, clinical characteristics of the sample are listed in Table 2, and t-test results comparing suicidality severity of those above and below clinical cutoffs for anxiety and depression are listed in Table 3.
![]() |
Table 2 Clinical Characteristics |
![]() |
Table 3 Comparison of Suicidality by Levels of Anxiety and Depression |
Suicidal Ideation and Self-Injurious Behaviors
The mean score on the IDAS was 8.44 (SD = 3.43). In the past 2 weeks, 34.6% of participants reported having at least some thoughts of suicide, 2.6% reported hurting themselves purposefully, 57.7% reported thinking about their own death, 14.0% reported thinking about hurting themselves, 1.3% reported cutting or burning themselves on purpose, and 27.6% reported thinking that the world would be better off without them. Responses to each of the IDAS items are reflected in Figure 1.
![]() |
Figure 1 IDAS Question Responses for Participants Who Endorsed Some Level of Suicidal Ideation or Self-Injurious Behaviors. |
Anxiety
The mean anxiety score on the OASIS was 6.60 (SD = 4.88); 39.1% of respondents (n = 84) had anxiety scores of 8 or above, indicating an increased likelihood of meeting criteria for anxiety diagnoses.20 An independent samples t-test was used to compare suicidality scores between those with anxiety scores of 8 or above (M = 9.76, SD = 4.07) and those with anxiety scores below 8 (M = 7.50, SD = 2.45). There was a significant difference between the groups, t(213) = 5.09, p < 0.001, with those with anxiety scores of 8 or above showing significantly higher suicidality scores. Bivariate correlation analysis revealed a moderate positive correlation between anxiety scores and suicidality scores, r = 0.429, p < 0.001.
Depression
The mean depression score on the ODSIS was 5.31 (SD = 5.36); 28.5% of respondents (n = 61) had depression scores of 8 or above, indicating an increased likelihood of meeting criteria for depression diagnoses.22 An independent samples t-test was used to compare suicidality scores between those with depression scores of 8 or above (M = 11.30, SD = 4.75) and those with depression scores below 8 (M = 7.38, SD = 1.90). There was a significant difference between the groups, t(212) = 8.64, p < 0.001, with those with ODSIS scores of 8 or above showing significantly higher IDAS scores. Bivariate correlation analysis revealed a moderate positive correlation between depression scores and suicidality scores, r = 0.545, p < 0.001.
Pain Intensity
The mean pain intensity was 5.24 (SD = 2.60); 62.9% of respondents (n = 144) had scores of 5 or above for pain intensity, indicating elevated orofacial pain.22 An independent samples t-test was used to compare suicidality scores between those with pain intensity scores of 5 or above (M = 8.90, SD = 3.84) and those with pain intensity scores below 5 (M = 7.66, SD = 2.43). There was a significant difference between the groups, t(227) = 2.69, p < 0.001, with those with pain intensity scores of 5 or above showing significantly higher suicidality scores.
Discussion
Despite the significant emotional distress and unique stressors associated with trigeminal neuralgia that may heighten suicide risk, there is a lack of research exploring suicidal ideation and self-injurious behaviors among large, nationwide samples of adults with this condition.4–6,8,15 This study reported rates and severity of suicidal ideation and self-injurious behaviors among a nationwide sample of adults with trigeminal neuralgia and related conditions and examined differences in suicidality severity between those with high and low levels of emotional distress and pain intensity in this population.
Rates of suicidal ideation and self-injurious behaviors were markedly high, with scores being over 5-fold higher than other pain samples, such as adults seeking treatment with lower back pain.24 Over a third of respondents reported having at least some thoughts of suicide in the past 2 weeks, 3 out of 10 participants reported thinking that the world would be better off without them, and almost 6 in 10 participants reported thinking about their own death. We also found high rates of anxiety and depression, with over a third of participants exceeding the cutoff used to discriminate against those likely to meet criteria for anxiety diagnoses, and almost 3 in 10 participants exceeding the cutoff used to discriminate against those likely to meet criteria for depression diagnoses.21,22 Elevated anxiety, depression, and pain were all significantly associated with elevated suicidality in our study population, and, consistent with existing literature, anxiety and depression were both moderately correlated with suicidality.25–27
These findings emphasize the high risk of suicidal ideation among those with trigeminal neuralgia and related neuralgias and convey an urgent need to screen and target suicidal ideation in this population. Results further highlight the importance of evaluating and targeting depression, anxiety, and pain in this population given their relevance to suicidality. To date, despite the unique challenges confronted by individuals with trigeminal neuralgia, no available interventions are specifically tailored to target suicidal ideation behaviors in this population.4,8 Results of this study support the need for development of such interventions.
Limitations of this study should be considered, such as the cross-sectional design, which prevents drawing of causal conclusions, and the limited racial and ethnic diversity of our sample. Future longitudinal studies with more diverse samples can further characterize suicide risk among those with trigeminal neuralgia and related neuralgias and inform intervention to help mitigate this risk.
Conclusion
Findings provide novel evidence on the alarming prevalence of suicidality among adults with trigeminal neuralgia and related neuralgias. There is an urgent need for suicide screening and interventions to reduce suicide risk among this population.
Acknowledgments
We would like to thank the Facial Pain Association for their contribution to data collection in this study.
Funding
This work has been supported by the National Center for Complementary and Integrative Health grants #K23AT01065301A1 to JG and #K23AT01236401A1 to JB.
Disclosure
The authors report no conflicts of interest in this work.
References
1. Aggarwal VR, McBeth J, Zakrzewska JM, et al. The epidemiology of chronic syndromes that are frequently unexplained: do they have common associated factors? Int J Epidemiol. 2006;35(2):468–476. doi:10.1093/ije/dyi265
2. Vickers E, Boocock H. Chronic orofacial pain is associated with psychological morbidity and negative personality changes: a comparison to the general population. Aust Dent J. 2005;50(1):21–30. doi:10.1111/j.1834-7819.2005.tb00081.x
3. Racine M. Chronic pain and suicide risk: a comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry. 2018;87:269–280. doi:10.1016/j.pnpbp.2017.08.020
4. Lovette BC, Bannon SM, Spyropoulos DC, Vranceanu AM, Greenberg J. “I still suffer every second of every day”: a qualitative analysis of the challenges of living with chronic orofacial pain. J Pain Res. 2022;15:2139–2148. doi:10.2147/JPR.S372469
5. Israel HA, Ward JD, Horrell B, Scrivani SJ. Oral and maxillofacial surgery in patients with chronic orofacial pain. J Oral Maxillofac Surg. 2003;61(6):662–667. doi:10.1053/joms.2003.50133
6. Beecroft EV, Durham J, Thomson P. Retrospective examination of the healthcare “journey” of chronic orofacial pain patients referred to oral and maxillofacial surgery. Br Dent J. 2013;214(5):E12. doi:10.1038/sj.bdj.2013.221
7. Peters S, Goldthorpe J, McElroy C, et al. Managing chronic orofacial pain: a qualitative study of patients’, doctors’, and dentists’ experiences. Br J Health Psychol. 2015;20(4):777–791. doi:10.1111/bjhp.12141
8. Grunberg VA, Reichman M, Lovette BC, Vranceanu AM, Greenberg J. “No one truly understands what we go through and how to treat it”: lived experiences with medical providers among patients with orofacial pain. Int J Environ Res Public Health. 2022;19(16):10396. doi:10.3390/ijerph191610396
9. Anita H, Putri FA, Maulina T. The association between orofacial pain and depression: a systematic review. JPR. 2024;17:785–796. doi:10.2147/JPR.S435219
10. Karamat A, Smith JG, Melek LNF, Renton T. Psychologic impact of chronic orofacial pain: a critical review. J Oral Facial Pain Headache. 2021;36(2):3010.
11. Rahardian MK, Putri FA, Maulina T. Association between orofacial pain and anxiety: a systematic review. JPR. 2024;17:1–10.
12. Aggarwal VR, Macfarlane GJ, Farragher TM, et al. Risk factors for onset of chronic oro-facial pain--results of the North Cheshire oro-facial pain prospective population study. Pain. 2010;149(2):354–359. doi:10.1016/j.pain.2010.02.040
13. Hawton K, Casañas I Comabella C, Haw C, Saunders K. Risk factors for suicide in individuals with depression: a systematic review. J Affect Disord. 2013;147(1):17–28. doi:10.1016/j.jad.2013.01.004
14. Bertoli E, de Leeuw R. Prevalence of suicidal ideation, depression, and anxiety in chronic temporomandibular disorder patients. J Oral Facial Pain Headache. 2016;30(4):296–301. doi:10.11607/ofph.1675
15. Dibello V, Panza F, Mori G, et al. Temporomandibular disorders as a risk factor for suicidal behavior: a systematic review. J Pers Med. 2022;12(11):1782. doi:10.3390/jpm12111782
16. Hooley JM, Franklin JC, Nock MK. Chronic pain and suicide: understanding the association. Curr Pain Headache Rep. 2014;18(8):435. doi:10.1007/s11916-014-0435-2
17. Zakrzewska JM, Linskey ME. Trigeminal neuralgia. BMJ. 2014;348:g474. doi:10.1136/bmj.g474
18. Melek LN, Devine M, Renton T. The psychosocial impact of orofacial pain in trigeminal neuralgia patients: a systematic review. Int J Oral Maxillofac Surg. 2018;47(7):869–878. doi:10.1016/j.ijom.2018.02.006
19. LaRowe LR, Bakhshaie J, Greenberg J. Substance use among adults with chronic orofacial pain. J Clin Psychol Med Settings. 2024;31(1):167–179.
20. Watson D, O’Hara MW, Simms LJ, et al. Development and validation of the Inventory of Depression and Anxiety Symptoms (IDAS). Psychol Assess. 2007;19(3):253–268. doi:10.1037/1040-3590.19.3.253
21. Norman SB, Hami Cissell S, Means-Christensen AJ, Stein MB. Development and validation of an Overall Anxiety Severity And Impairment Scale (OASIS). Depress Anxiety. 2006;23(4):245–249. doi:10.1002/da.20182
22. Bentley KH, Gallagher MW, Carl JR, Barlow DH. Development and validation of the overall depression severity and impairment scale. Psychol Assess. 2014;26(3):815–830. doi:10.1037/a0036216
23. Krebs EE, Lorenz KA, Bair MJ, et al. Development and initial validation of the PEG, a three-item scale assessing pain intensity and interference. J Gen Intern Med. 2009;24(6):733–738. doi:10.1007/s11606-009-0981-1
24. Kaye S, Wygant DB, Umlauf RL, Marek RJ. Factor structure and validity of the Inventory of Depression and Anxiety Symptoms-II (IDAS-II) in a chronic back pain treatment-seeking sample. Psychol Assess. 2022;34(1):3–9. doi:10.1037/pas0001057
25. Kanwar A, Malik S, Prokop LJ, et al. The association between anxiety disorders and suicidal behaviors: a systematic review and meta-analysis. Depress Anxiety. 2013;30:917–929. doi:10.1002/da.22074
26. Hawton K, Comabella CC, Haw C, et al. Risk factors for suicide in individuals with depression: a systematic review. J Affect Disord. 2012;147(1–3):17–28.
27. Angst J, Angst F, Stassen HH. Suicide risk in patients with major depression disorder. J Clin Psychiatry. 1999;60(2):57–62.
© 2025 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms.php
and incorporate the Creative Commons Attribution
- Non Commercial (unported, 4.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
Recommended articles

Alleviating Excessive Worries Improves Co-Occurring Depression and Pain in Adolescent and Young Adult Cancer Patients: A Network Approach
Li W, Xu Y, Luo X, Wen Y, Ding K, Xu W, Garg S, Yang Y, Sun H
Neuropsychiatric Disease and Treatment 2022, 18:1843-1854
Published Date: 25 August 2022

Predictive Validity and Patterns of Change Over Time of the Sensitivity to Pain Traumatization Scale: A Trajectory Analysis of Patients Seen by the Transitional Pain Service Up to Two Years After Surgery
Fashler SR, Pagé MG, Svendrovski A, Flora DB, Slepian PM, Weinrib AZ, Huang A, Fiorellino J, Clarke H, Katz J
Journal of Pain Research 2022, 15:2587-2605
Published Date: 31 August 2022

The Interconnection Between Social Support and Emotional Distress Among Individuals with Chronic Pain: A Narrative Review
Franqueiro AR, Yoon J, Crago MA, Curiel M, Wilson JM
Psychology Research and Behavior Management 2023, 16:4389-4399
Published Date: 27 October 2023
Studies on Pain Associated with Anxiety or Depression in the Last 10 Years: A Bibliometric Analysis
Zhang Q, Sun H, Xin Y, Li X, Shao X
Journal of Pain Research 2024, 17:133-149
Published Date: 5 January 2024

AI Technology panic—is AI Dependence Bad for Mental Health? A Cross-Lagged Panel Model and the Mediating Roles of Motivations for AI Use Among Adolescents
Huang S, Lai X, Ke L, Li Y, Wang H, Zhao X, Dai X, Wang Y
Psychology Research and Behavior Management 2024, 17:1087-1102
Published Date: 12 March 2024